XWELL Inc. (XWEL)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $5.62M
Last updated: Nov 17, 2026 at 11:02 AM ET
XWELL Inc. (XWEL) Competitors
The companies most similar to XWELL are bioAffinity Technologies (BIAF), MDxHealth SA (MDXH) and iSpecimen (ISPC). By market cap, XWELL ranks 5th of the 13 companies on this page; Precipio (PRPO) is the largest at $39.68M.
Peer Comparison
XWEL's revenue growth of -7.1% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| XWELL (XWEL) | $5.62M | N/A | 0.2x | -82.9% | N/A | -7.1% | 0.00% |
| bioAffinity Technologies, Inc. (BIAF) | $4.00M | N/A | 0.3x | -278.9% | -376.1% | -26.0% | 0.00% |
| MDxHealth SA (MDXH) | $13.75M | N/A | N/A | -38.3% | -40.5% | -17.2% | 0.00% |
| iSpecimen Inc (ISPC) | $1.66M | N/A | 1.8x | 0.0% | N/A | -78.7% | 0.00% |
| WORK Medical Technology Group LTD Ordinary Shares (WOK) | $5.36M | N/A | N/A | -41.9% | -17.8% | 19.1% | 0.00% |
| Wellchange Holdings Company Limited (WCT) | $7.67M | N/A | 0.2x | 0.0% | N/A | -44.1% | 0.00% |
| Nuwellis Inc (NUWE) | $2.65M | N/A | N/A | -125.6% | N/A | 14.1% | 0.00% |
| XTL Biopharmaceuticals Ltd ADR (XTLB) | $3.93M | N/A | 4.0x | 0.0% | N/A | 0.0% | 0.00% |
| Precipio Inc (PRPO) | $39.68M | N/A | 1.3x | -4.1% | -5.7% | 8.3% | 0.00% |
| Jaguar Animal Health Inc (JAGX) | $5.59M | N/A | N/A | -130.8% | -98.4% | -58.9% | 0.00% |
| Exicure Inc (XCUR) | $7.07M | N/A | N/A | 0.0% | N/A | 928.0% | 0.00% |
| Skye Bioscience, Inc. Common Stock (SKYE) | $4.83M | N/A | N/A | 0.0% | -3685.3% | 0.0% | 0.00% |
| Beyond Air Inc (XAIR) | $3.55M | N/A | 0.5x | 0.0% | -113.5% | 0.5% | 0.00% |
| Peer median | $5.09M | N/A | 0.9x | -2.1% | -98.4% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to XWELL, ranked by how closely their business, size, sector and industry match. The largest groups, 4 each of the 12, are in Biotechnology and Diagnostics & Research; the other 4 span 2 industries.
| Company | About | Peers |
|---|---|---|
| bioAffinity Technologies, Inc. (BIAF)Diagnostics & Research | bioAffinity Technologies, Inc., a biotechnology company, is engaged in the development of non-invasive diagnostic tests and specific treatments for cancer. | BIAF competitors |
| MDxHealth SA (MDXH)Diagnostics & Research | MDxHealth SA is a prominent biotechnology company focused on precision diagnostics that enhance cancer management, particularly in prostate and bladder cancers. | MDXH competitors |
| iSpecimen Inc (ISPC)Diagnostics & Research | iSpecimen, Inc. provides technology that connects life science researchers in need of human biofluids... | ISPC competitors |
| WORK Medical Technology Group LTD Ordinary Shares (WOK)Medical Devices | WORK Medical Technology Group Ltd is a pioneering player in the medical technology sector, dedicated to the advancement of healthcare through the research... | |
| Wellchange Holdings Company Limited (WCT)Software - Application | Wellchange Holdings Company Limited (WCT) is a progressive player in the healthcare and wellness sector... | |
| Nuwellis Inc (NUWE)Medical Devices | Nuwellis, Inc., a medical device company, focuses on the development, manufacture and marketing of medical devices used in ultrafiltration therapy. | NUWE competitors |
| XTL Biopharmaceuticals Ltd ADR (XTLB)Biotechnology | XTL Biopharmaceuticals Ltd., a biopharmaceutical company, is engaged in the acquisition and development of pharmaceutical products for the treatment... | |
| Precipio Inc (PRPO)Diagnostics & Research | Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market. | PRPO competitors |
| Jaguar Animal Health Inc (JAGX)Biotechnology | Jaguar Health, Inc., a commercial-stage pharmaceutical company, focuses on developing prescription drugs for people and animals with gastrointestinal upset... | JAGX competitors |
| Exicure Inc (XCUR)Biotechnology | Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases... | XCUR competitors |
| Skye Bioscience, Inc. Common Stock (SKYE)Biotechnology | Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops... | SKYE competitors |
| Beyond Air Inc (XAIR)Medical Devices | Beyond Air, Inc., a clinical-stage biopharmaceutical and medical device company, develops nitric oxide (NO) generators and delivery systems. | XAIR competitors |
Frequently Asked Questions About XWEL
Who are XWELL's main competitors?
The companies most similar to XWELL include bioAffinity Technologies (BIAF), MDxHealth SA (MDXH), iSpecimen (ISPC), WORK Medical Technology Group LTD Ordinary Shares (WOK) and Wellchange Holdings Company (WCT), listed from the closest match.
Who is XWELL's biggest competitor?
Precipio (PRPO) is the largest of the similar companies at $39.68M; bioAffinity Technologies (BIAF) is the closest match by business profile, size, sector and industry.
How does XWEL stock compare with its competitors?
XWEL's P/S is 0.2x against a peer median of 0.9x; its net margin is -82.9% against a peer median of -2.1%.
Which of XWELL's competitors pays a higher dividend?
XWELL pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is XWELL bigger than its competitors?
No. XWELL is 5th by market cap among the 13 companies on this page; the largest is Precipio (PRPO) at $39.68M.
XWEL pages: Overview, Earnings, Financials, Valuation, Competitors, Government Contracts